LITHIUM 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE, 95%, 250mg

3-(1H-tetrazol-5-yl)morpholine hydrochloride, 95.0%, 1g

1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate, 95.0%, 1g

1-Cyclohexenecarbonitrile, 98.0%, 2g

3'-Acetamidoacetophenone, 95.0%, 25g

2-Fluorophenylmethylsulfone, 98.0%, 1g

4-(4-Benzylphenyl)-1,3-thiazol-2-amine, 95.0%, 1mg

Methyl 3-(4-chlorophenyl)-3-hydroxypropanoate, 500mg

Tri-o-tolyl Borate>98.0%(T)5mL

E-Plan-Phase EPLPH 20x/0,40 Objektiv. Arbeitsabstand 1,85 mm

7-bromo-1H,2H,3H,4H-thieno[3,2-d]pyrimidine-2,4-dione, 95%, 10g

4-(4-Bromo-2-fluorobenzyl)morpholine, 95.0%, 1g

4-(Benzyloxy)pyridin-2(1H)-one, 97.0%, 5g